Chemical Synthesis and NMR Characterization of Non Steroidal Mimics of an Estradiol Derivative Used as Inhibitor of 17beta-Hydroxysteroid Dehydrogenase Type 1


  •  Guy Bertrand Djigoué    
  •  René Maltais    
  •  Charles Ouellet    
  •  Alexandre Trottier    
  •  Donald Poirier    

Abstract

Inhibiting estradiol (E2) biosynthesis through 17?-hydroxysteroid dehydrogenase type 1 (17?-HSD1) inhibitors is a promising strategy for breast cancer therapy. We have designed a non-steroidal template to mimic CC-156, a potent steroidal inhibitor of 17?-HSD1. Starting from tetrahydro-isoquinolinol hydrobromide, two representative compounds were synthesized in six chemical steps: protection of the amino group, protection of the phenol, hydrolysis of the N-protecting group Fmoc, nucleophilic substitution to introduce an ethyloxirane, phenolysis with meta or para hydroxybenzamide and the hydrolysis of the MOM protecting group. Although the compounds showed a good fit when docked in the catalytic site of the enzyme, conserving the key interactions with amino acids His221 and Ser142, observed from the crystalline structure of inhibitor CC-156 with 17?-HSD1, they weakly inhibited 17?-HSD1. However, they did not show estrogenic activity when tested in vitro, suggesting the potential of this non-steroidal template for drug design. Furthermore, the synthetic approach reported here opens a door to the preparation of additional non-steroidal mimics of E2 derivatives, which could be tested on 17?-HSD1 and others biological targets.


This work is licensed under a Creative Commons Attribution 4.0 License.
  • Issn(Print): 1916-9698
  • Issn(Onlne): 1916-9701
  • Started: 2009
  • Frequency: semiannual

Journal Metrics

Google-based Impact Factor (2018): 10.07

h-index (August 2018): 23

i10-index (August 2018): 76

h5-index (August 2018): 9

h5-median(August 2018): 14

( The data was calculated based on Google Scholar Citations. Click Here to Learn More. )

Contact